Even at this incredibly slow time of the year for blog traffic, we hit about 250% of our average readership yesterday with search engines finding our post on Allergan's new eyelash enhancing cosmeceutical, Latisse.
Lots of folks wanting to know where to buy Latisse - Allergan stock anyone?
(Aside: Among my other search term hits yesterday was: "'junior faculty' hate my job." It hit an older post on whether junior faculty should invest time in writing review articles. I suggest that the reader start adding feeds to many of our commenters who with whom they may be able to commiserate.)
- Log in to post comments
More like this
The tagline is from Elaine D'Farley at Self magazine talking about the FDA's then-pending approval of Allergan's Latisse™ for cosmetic growth of longer, thicker eyelashes treatment of hypotrichosis of the eyelashes. While not expected until early 2009, Jacob Goldstein at the WSJ Health Blog clued…
This whole "cosmeceutical" thing probably shouldn't be in "Medicine & Health" but we did call your attention to today's news item back on 27 July 2007: Drug maker Allergan announced at a stock analyst's meeting this afternoon that it is filing a New Drug Application (NDA) for a cosmetic form…
The existence of the drug Latisse is clearly a harbinger of the end of modern civilization, in more ways than one, but it is also intensely fascinating and creepy. When I first heard of it, about a year ago, I really thought it was some sort of satirical article about the current status of big…
This is the second post in which I'm pulling a revise-and-extend job on some things I said at Science Online at a few panels on bloggy stuff: in the how-to-do-outreach session (posted yesterday, the blogging long term session, and the what-to-do-when-people-start-taking-you-seriously session. In…
search hits always interest me.
for a while i got a lot of hits on a search term along the lines of "flunk out of grad school", hitting a post where i had smacked down on some unrealistic whining i heard from a younger student.